Encompass Health Corporation

Fundamentals7.0
Price Action6.0
News Sentiment7.0
AI Rating
7.0

Key Drivers

  • Solid profitability
  • Elevated leverage
  • Strong cash flow

AI
AI Summary

7.0

EHC is now a premium-valued growth execution story: investors should hold or add only if new-hospital expansion sustains 6–8% discharge growth while free cash flow recovers and leverage declines, as labor inflation, elevated capex, and debt leave little room for operational misses.

GrowthExecution
LeverageRisk

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

7.0

Key Financial Insights:

  • •Solid profitability
  • •Elevated leverage
  • •Strong cash flow

EHC delivers solid profits and cash flow, but elevated leverage, limited cash, noncontrolling interests, and richer valuation warrant caution.

Profitability
Leverage

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • •Mild upward trend
  • •Resistance rejection
  • •Support holding

EHC was slightly higher over the last month but momentum has softened below $124.00 resistance, with $120.10–$120.50 support pivotal for the next move.

EHC
TechnicalAnalysis
Support Level: $120.10–$120.50
Resistance Level: $123.90–$124.00

Pullback followed the $123.91 peak on 2026-09-16

Sentiment & News

7.0

Key News Insights:

  • •Hospital Expansion
  • •Demand Growth
  • •Valuation Risks

Encompass Health's expansion, rising demand, and improving leverage support a bullish long-term outlook, though valuation, expenses, and debt remain key risks.

Growth

Growth initiatives and new facility openings are likely supportive for the stock, but premium valuation could limit near-term upside